期刊文献+

阿托伐他汀对不稳定型心绞痛患者血清高敏C反应蛋白和血脂的影响 被引量:8

下载PDF
导出
摘要 不稳定型心绞痛是不稳定的动脉粥样硬化斑块破裂,表面破损或裂纹,引起不完全阻塞血栓的急性病变,导致血管出现急性炎症反应。近年来,随着对动脉粥样硬化研究的不断深入,许多炎症因子被发现与动脉粥样硬化有关,炎症已经被公认是动脉粥样硬化发展过程中的核心因素。
出处 《中国药物与临床》 CAS 2011年第6期726-727,共2页 Chinese Remedies & Clinics
  • 相关文献

参考文献5

二级参考文献19

  • 1刘甲兴,郑兴,秦永文,丁继军,赵仙先,曹江.脂蛋白相关性磷脂酶A_2活性能反映冠状动脉粥样硬化病变程度[J].第二军医大学学报,2006,27(4):391-395. 被引量:31
  • 2Albert MA Danielson E,Rifai N,et aI.Effeet of statin therapy on creative protein levels:the pravastatin inflammation /CRP evaluation (PRINE):a randomizen trial and cohort study. JAMA, 2001,286:64-70.
  • 3Ross R. Cell biology of atherosclerosis. Ann Rev Physiol, 1995, 57 : 791-795.
  • 4Six DA,Dennis EA. The expanding superfamily of phospholipase A2 enzymes:classification and characterization. Biochim Biophys Acta,2000,1488(1-2) : 1-19.
  • 5Caslake MJ,Packard CJ,Suckling KE,et al. Lipoprotein-associated phosphohpeseA2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis, 2000,150(2) :413-419.
  • 6Hakkinen T, Luoma JS, Hiltunen MO, et al. Lipoprotein-associated phospholipase A2,platelet-activating factor acetylhydrolase,is expressed by macrophages in human and rabbit atheroselerotic lesions. Arterioscler Thromb Vase Biol,1999,19 (12):2909- 2917.
  • 7Kolodgie FD,Burke AP, Skorija KS, et al. Lipoprotein-assoeiated phospholipaseA2 protein expression in the natural progression of human coronary atherosclerosis. Arterioseler Thromb Vase Biol, 2006,26( 11 ) : 2523-2529.
  • 8Macphee CH. Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target. Curr Opin Pharmacol,2001,1(2) : 121-125.
  • 9Packard C J, O'Reilly DS, Caslake MJ, et al. Lipoprotein-assoeiated phospholipase A2 as an independent predictor of coronary heart disease west of scotland coronary prevention study group. N Engl J Med,2000,343(16) : 1148-1155.
  • 10Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the atherosclerosis risk in communities (ARIC) study. Circulation, 2004,109(7 ) : 837-842.

共引文献188

同被引文献75

  • 1董炳庆,侯健,方毅民,杨军.早期应用阿托伐他汀对急性心肌梗死再灌注的影响[J].临床心血管病杂志,2006,22(4):198-200. 被引量:7
  • 2杨莉莉,赵宇.C反应蛋白水平与急性冠状动脉综合征预后的关系[J].医学研究杂志,2006,35(6):66-67. 被引量:5
  • 3张冬颖,覃数,唐显军,杨辉.辛伐他汀对心肌梗死后大鼠心肌间质重构的影响[J].中国药理学通报,2007,23(4):516-520. 被引量:9
  • 4陈灏珠,主编.实用内科学[M]第12版.北京:人民卫生出版社,2005.1 231-1 245.
  • 5中华医学会心血管病分会 中华心血管杂志编辑委员会.不稳定型心绞痛诊断和治疗建议.中华心血管病杂志,2000,:4209-4212.
  • 6高润霖,吴宁,胡大一,等.心血管病治疗指南和建议[M].北京:人民军医出版社,2005:261-315
  • 7赵秀峰.刘丽军.信栓力.等.阿托伐他汀对不稳定,弛山绞痛患者血浆MCP-1、hsCRP水平的影响[J].两南军医,2010,12(5):841-842.
  • 8吴杞,欧阳颀.图解耳压疗法[M].北京:人民军医出版社,2011:8.
  • 9中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高性心肌梗死诊断和治疗指南.中华心血管病杂志,2010,38:675-687.
  • 10Gregory G, Anders G, Michael D, et al. Effects of arorvastarin on early recurrent is chemic evenly in acute coronary syndromes the MIRACL study: a randomized controlled trial. JAMA, 2001, 285 : 1711-1718.

引证文献8

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部